EU Added to Approved Jurisdictions, Allowing Faster Clinical Waivers

Amendments to Rule 63 expand the list of recognised strict regulatory jurisdictions for devices that do not require a predicate. The European Union is now included alongside the United States, United Kingdom, Australia, Canada and Japan. This alignment lets manufacturers leverage EU‑cleared exemptions, shortening clinical investigation timelines and bringing advanced technologies to Indian patients more quickly.